Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Pacira BioSciences (PCRX) Shares Issued (2016 - 2026)

Pacira BioSciences has reported Shares Issued over the past 16 years, most recently at $2000.0 for Q1 2026.

For Q1 2026, Shares Issued changed N/A year-over-year to $2000.0; the TTM value through Mar 2026 reached $492000.0, changed N/A, while the annual FY2025 figure was $502000.0, N/A changed from the prior year.
Shares Issued for Q1 2026 was $2000.0 at Pacira BioSciences, down from $490000.0 in the prior quarter.
Over five years, Shares Issued peaked at $11.0 million in Q1 2022 and troughed at $2000.0 in Q1 2026.
A 4-year average of $3.0 million and a median of $905000.0 in 2022 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: surged 91.41% in 2022 and later tumbled 98.38% in 2023.
Year by year, Shares Issued stood at $905000.0 in 2022, then plummeted by 97.13% to $26000.0 in 2023, then skyrocketed by 1784.62% to $490000.0 in 2025, then crashed by 99.59% to $2000.0 in 2026.
Business Quant data shows Shares Issued for PCRX at $2000.0 in Q1 2026, $490000.0 in Q4 2025, and $26000.0 in Q3 2023.